Elevated Foxp3+ double-negative T cells are associated with disease progression during HIV infection

Leidan Zhang, Yuqing Wei, Di Wang, Juan Du, Xinyue Wang, Bei Li, Meiqing Jiang, Mengyuan Zhang, Na Chen, Meiju Deng, Chuan Song, Danying Chen, Liang Wu, Jiang Xiao, Hongyuan Liang, Hongxin Zhao, Yaxian KongFrontiers in Immunology 2022 · DOI

TL;DR

This study identifies a specific subset of immune cells, Foxp3+ double-negative T cells (DNTs), that accumulate in individuals with advanced HIV infection. These cells appear to play a role in immune suppression and are linked to disease progression, suggesting they could be a novel target for therapeutic interventions to manage HIV-associated immune activation.

What Problem Does This Paper Address?

HIV infection is characterized by chronic immune activation, which leads to the depletion of crucial CD4+ T cells and the progression to AIDS. This persistent activation also hinders effective immune reconstitution even with antiretroviral therapy (ART) and contributes to non-AIDS related health issues. Identifying ways to control this immune activation is therefore critical for better HIV management. While double-negative T cells (DNTs) are known to have immunosuppressive functions, their specific role and mechanisms in HIV, particularly concerning the key regulatory molecule Foxp3, remained unclear. This paper aims to investigate whether DNTs express Foxp3 and how this influences their function and association with HIV disease progression.

Methods

The researchers employed a multi-faceted approach using flow cytometry to analyze immune cell populations in blood samples. Key techniques included:

  • Immunofluorescence Staining and Flow Cytometry: This standard technique was used to identify and quantify different immune cell subsets, specifically focusing on the expression of Foxp3, CD3, CD4, CD8, and other surface and intracellular markers (e.g., CD39, CD25, GITR, Ki-67, CTLA-4, LAG-3, FasL, Granzyme A/B, Perforin, IDO, IL-10).
  • Intracellular Staining: This was crucial for detecting intracellular Foxp3 expression within DNTs.
  • Plasma Cytokine and Chemokine Analysis: Luminex assays were used to measure the levels of various inflammatory markers in patient plasma.
  • Statistical Analysis: A range of statistical tests (Kruskal-Wallis, Mann-Whitney U, Spearman correlation) were used to compare groups and assess relationships between different immune parameters and clinical data.

Datasets

The study utilized peripheral blood samples from:

  • Healthy Controls (HCs): 25 individuals.
  • Treatment-Naïve HIV-infected Patients (TNs): 121 individuals, further stratified by CD4+ T cell count (<200 cells/µl, 200-350 cells/µl, and ≥350 cells/µl).
  • HIV-infected Patients on ART (ARTs): 32 individuals who had been on ART for a median of 5.2 years with a baseline CD4+ T cell count <200 cells/µl.

No new datasets or benchmarks were introduced; the study relied on existing patient cohorts.

Key Insights and Ideas

  • Foxp3+ DNTs as a Biomarker of Disease Severity: The most striking finding is the significant accumulation of Foxp3+ DNT cells in HIV-infected individuals with low CD4+ T cell counts (<200 cells/µl), suggesting these cells are associated with advanced disease progression.
  • Immunosuppressive Potential: The expression of Foxp3, a key regulator of T regulatory cells (Tregs), on DNTs points towards an immunosuppressive role for this specific DNT subset in HIV.
  • Link to Immune Activation: The frequency of Foxp3+ DNT cells positively correlated with markers of immune activation (e.g., HLA-DR+CD38hi CD4+ and CD8+ T cells) and systemic inflammation, indicating their involvement in the broader inflammatory landscape of HIV.
  • Unique Phenotypic Characteristics: Foxp3+ DNT cells exhibit a distinct profile compared to Foxp3- DNT cells, showing increased expression of CD39 and CD25, and higher levels of GITR and Ki-67, suggesting enhanced activation and proliferation.
  • Partial Reversibility with ART: The elevated levels of Foxp3+ DNT cells were found to be significantly reduced in patients who had undergone successful ART, indicating that their accumulation is linked to active viral replication and immune activation, and can be partially reversed.

Key Results

  • Accumulation in Advanced HIV: Foxp3+ DNT cells were significantly elevated in frequency and absolute number in treatment-naïve PLWH with CD4+ T cell counts <200 cells/µl compared to healthy controls and PLWH with higher CD4+ counts.
  • Negative Correlation with CD4 Count: The percentage of Foxp3+ DNT cells showed a strong negative correlation with CD4+ T cell count (r = -0.5862, P < 0.0001) and CD4/CD8 ratio (r = -0.5341, P < 0.0001).
  • Positive Correlation with Viral Load: A slight positive correlation was observed between Foxp3+ DNT cell frequency and viral load (r = 0.27, P = 0.0025).
  • Association with Immune Activation: Foxp3+ DNT cell frequency positively correlated with CD38hiHLA-DR+ CD4+ T cells (r = 0.6338, P < 0.0001) and CD38hiHLA-DR+ CD8+ T cells (r = 0.4577, P < 0.0001).
  • Inflammatory Markers: Higher Foxp3 expression on DNT cells was associated with increased levels of inflammatory cytokines like I-TAC, IL-6, IL-8, and MCP-1.
  • ART Impact: ART-experienced patients showed significantly decreased proportions and absolute numbers of Foxp3+ DNT cells compared to treatment-naïve patients.

Limitations and Future Work

The authors acknowledge several limitations:

  • Functional Assays: It was difficult to directly confirm the suppressive role of Foxp3+ DNT cells in vitro due to challenges in isolating viable Foxp3+ cells.
  • Confounding Factors: Distinguishing the effects of HIV itself from those of opportunistic infections, which are common in individuals with low CD4+ counts, was challenging.
  • Cohort Bias: The study cohort was heavily skewed towards men who have sex with men (MSM), and women may exhibit different immune responses to HIV.

Future work should focus on:

  • Developing methods to isolate and functionally assess Foxp3+ DNT cells in vitro to definitively prove their suppressive capacity.
  • Investigating these findings in a gender-balanced cohort to ensure broader applicability.
  • Exploring the precise mechanisms by which Foxp3+ DNT cells exert their regulatory functions and how they might be therapeutically modulated to control immune activation in HIV.

Summary updated

Abstract

Persistent immune activation, which occurs during the whole course of HIV infection, plays a pivotal role in CD4<sup>+</sup> T cells depletion and AIDS progression. Furthermore, immune activation is a key factor that leads to impaired immune reconstitution after long-term effective antiretroviral therapy (ART), and is even responsible for the increased risk of developing non-AIDS co-morbidities. Therefore, it's imperative to identify an effective intervention targeting HIV-associated immune activation to improve disease management. Double negative T cells (DNT) were reported to provide immunosuppression during HIV infection, but the related mechanisms remained puzzled. Foxp3 endows Tregs with potent suppressive function to maintain immune homeostasis. However, whether DNT cells expressed Foxp3 and the accurate function of these cells urgently needed to be investigated. Here, we found that Foxp3<sup>+</sup> DNT cells accumulated in untreated people living with HIV (PLWH) with CD4<sup>+</sup> T cell count less than 200 cells/µl. Moreover, the frequency of Foxp3<sup>+</sup> DNT cells was negatively correlated with CD4<sup>+</sup> T cell count and CD4/CD8 ratio, and positively correlated with immune activation and systemic inflammation in PLWH. Of note, Foxp3<sup>+</sup> DNT cells might exert suppressive regulation by increased expression of CD39, CD25, or vigorous proliferation (high levels of GITR and ki67) in ART-naive PLWH. Our study underlined the importance of Foxp3<sup>+</sup> DNT cells in the HIV disease progression, and suggest that Foxp3<sup>+</sup> DNT may be a potential target for clinical intervention for the control of immune activation during HIV infection.
BibTeX
@inproceedings{zhang2022elevated,
  author = {Leidan Zhang and Yuqing Wei and Di Wang and Juan Du and Xinyue Wang and Bei Li and Meiqing Jiang and Mengyuan Zhang and Na Chen and Meiju Deng and Chuan Song and Danying Chen and Liang Wu and Jiang Xiao and Hongyuan Liang and Hongxin Zhao and Yaxian Kong},
  title = {{Elevated Foxp3+ double-negative T cells are associated with disease progression during HIV infection}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2022.947647},
}
Figure